Search Results - "Gonzalez‐Moreno, Santiago"
-
1
The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery
Published in Journal of surgical oncology (01-12-2014)“…Background Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) are gaining acceptance as treatment for selected patients with…”
Get full text
Journal Article -
2
POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1
Published in Molecular oncology (01-03-2024)“…The small GTPase Rac1 (Ras‐related C3 botulinum toxin substrate 1) has been implicated in cancer progression and in the poor prognosis of various types of…”
Get full text
Journal Article -
3
Prioritization, patient selection, and multimodal perioperative management of colorectal cancer facing health-care system saturation
Published in Cirugia y cirujanos (2021)“…The aim is to analyze the usefulness of pre-operative COVID-19 screening to detect asymptomatic patients, the capability of our patient selection algorithm to…”
Get full text
Journal Article -
4
A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process
Published in The American journal of surgical pathology (01-01-2016)“…Pseudomyxoma peritonei (PMP) is a complex disease with unique biological behavior that usually arises from appendiceal mucinous neoplasia. The classification…”
Get full text
Journal Article Conference Proceeding -
5
The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery
Published in JAMA surgery (01-03-2021)“…Studies on the prognostic role of hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei (PMP) are currently not available. To evaluate…”
Get more information
Journal Article -
6
The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies
Published in Annals of surgical oncology (01-10-2024)“…This manuscript reports the results of an international consensus on technologies of hyperthermic intraperitoneal perioperative chemotherapy (HIPEC) performed…”
Get full text
Journal Article -
7
Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Published in Journal of clinical oncology (10-07-2012)“…Pseudomyxoma peritonei (PMP) originating from an appendiceal mucinous neoplasm remains a biologically heterogeneous disease. The purpose of our study was to…”
Get full text
Journal Article -
8
Classic and Visceral-Sparing Complete Pelvic Peritonectomy for Peritoneal Surface Malignancies: A Video Demonstration in Female Patients
Published in Annals of surgical oncology (10-10-2024)“…Cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy has become standard for resectable peritoneal surface malignancies. CRS…”
Get full text
Journal Article -
9
The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis
Published in Annals of surgical oncology (01-12-2014)“…ABSTRACT Background Extensive clinical experience suggests that hyperthermic intraperitoneal chemotherapy (HIPEC) may play an important role in the management…”
Get full text
Journal Article -
10
Learning Curve, Training Program, and Monitorization of Surgical Performance of Peritoneal Surface Malignancies Centers
Published in Surgical oncology clinics of North America (01-07-2018)“…Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is a complex procedure with high cost and significant morbidity and mortality. The…”
Get full text
Journal Article -
11
Education and Training in Peritoneal Surface Oncology
Published in Journal of surgical oncology (24-09-2024)“…Peritoneal surface oncology (PSO) is a novel field dealing with the knowledge of peritoneal neoplasms, primary or secondary, and their clinical management. As…”
Get full text
Journal Article -
12
Radical appendectomy as an alternative to right colon resection in patients with epithelial appendiceal neoplasms
Published in Surgical oncology (01-03-2017)“…Abstract Objective Appendectomy is an extremely common surgical procedure usually performed for an inflammatory process within this organ. Upon occasion, the…”
Get full text
Journal Article -
13
Review of 2022 PSOGI/RENAPE Consensus on HIPEC
Published in Journal of surgical oncology (16-09-2024)“…The 2022 PSOGI (Peritoneal Surface Oncology Group International) and RENAPE (French Network for Rare Peritoneal Malignancies) consensus on hyperthermic…”
Get full text
Journal Article -
14
Nephrotoxicity Associated with Cytoreductive Surgery Combined with Cisplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignant Disease: A Systematic Review and Meta-Analysis
Published in Journal of clinical medicine (28-06-2024)“…Cisplatin is employed in hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery (CRS) for peritoneal surface malignancies (PSMs). The…”
Get full text
Journal Article -
15
Intestinal mucormycosis as a differential diagnosis of small bowel ischemia
Published in Revista española de enfermedades digestivas (01-10-2024)“…Intestinal mucormycosis is a rare manifestation of the Mucor fungus, associated with high mortality and typically found in immunocompromised patients, though…”
Get full text
Journal Article -
16
Peritoneal Surface Oncology: A progress report
Published in European journal of surgical oncology (01-08-2006)“…The Fourth International Workshop on Peritoneal Surface Malignancy took place in Madrid (Spain) on December 2, 3 and 4, 2004. The meeting brought together 132…”
Get full text
Journal Article Conference Proceeding -
17
The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI)
Published in European journal of surgical oncology (01-11-2021)“…The PRODIGE 7-trial investigated the additional value of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to cytoreductive surgery (CRS) for patients with…”
Get full text
Journal Article -
18
-
19
Hyperthermic intraperitoneal chemotherapy:Rationale and technique
Published in World journal of gastrointestinal oncology (15-02-2010)“…The combination of complete cytoreductive surgery and perioperative intraperitoneal chemotherapy provides the only chance for long-term survival for selected…”
Get full text
Journal Article -
20
Peritoneal Carcinomatosis: Cytoreductive Surgery and HIPEC--Overview and Basics
Published in Cancer investigation (01-03-2012)“…Tumor involvement of the peritoneum-peritoneal carcinomatosis-is a heterogeneous form of cancer that had been generally regarded as a sign of systemic tumor…”
Get full text
Journal Article